[1] 中国国家药监局药品审评中心(CDE)官网.Retrieved Apr 7,2022, from https://www.cde.org.cn/main/xxgk/listpage/9f9c74c73e0f8f56a8bfbc646055026d
[2] 盐野义公司官网. from https://www.shionogi.com/global/en/innovation/pipeline.html[3]Shionogi Receives European Commission Marketing Authorisation for FETCROJA® (cefiderocol) for the Treatment of Infections Due to Aerobic Gram-negative Bacteria in Adults With Limited Treatment Options. Retrieved April 27, 2020 from https://www.businesswire.com/news/home/20200427005719/en/Shionogi-Receives-European-Commission-Marketing-Authorisation-FETCROJA%C2%AE